Natixis’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
28,662
+3,745
| +15% | +$258K | 0.01% | 470 |
|
|
2025
Q1 | $1.71M | Sell |
24,917
-2,881
| -10% | -$197K | 0.01% | 441 |
|
|
2024
Q4 | $2.39M | Buy |
27,798
+25,192
| +967% | +$2.17M | 0.01% | 424 |
|
|
2024
Q3 | $310K | Buy |
2,606
+2,420
| +1,301% | +$288K | ﹤0.01% | 666 |
|
|
2024
Q2 | $26.6K | Sell |
186
-5,717
| -97% | -$816K | ﹤0.01% | 795 |
|
|
2024
Q1 | $758K | Buy |
5,903
+5,207
| +748% | +$669K | ﹤0.01% | 547 |
|
|
2023
Q4 | $72K | Sell |
696
-803
| -54% | -$83.1K | ﹤0.01% | 778 |
|
|
2023
Q3 | $136K | Buy |
+1,499
| New | +$136K | ﹤0.01% | 742 |
|
|
2022
Q2 | – | Sell |
-3,798
| Closed | -$211K | – | 1187 |
|
|
2022
Q1 | $211K | Buy |
3,798
+90
| +2% | +$5K | ﹤0.01% | 1106 |
|
|
2021
Q4 | $208K | Buy |
+3,708
| New | +$208K | ﹤0.01% | 1172 |
|
|
2019
Q2 | – | Sell |
-24,140
| Closed | -$628K | – | 856 |
|
|
2019
Q1 | $628K | Buy |
24,140
+5,092
| +27% | +$132K | ﹤0.01% | 644 |
|
|
2018
Q4 | $439K | Sell |
19,048
-396
| -2% | -$9.13K | ﹤0.01% | 592 |
|
|
2018
Q3 | $458K | Buy |
19,444
+5,526
| +40% | +$130K | ﹤0.01% | 641 |
|
|
2018
Q2 | $321K | Buy |
13,918
+5,326
| +62% | +$123K | ﹤0.01% | 752 |
|
|
2018
Q1 | $212K | Buy |
8,592
+476
| +6% | +$11.7K | ﹤0.01% | 834 |
|
|
2017
Q4 | $218K | Buy |
+8,116
| New | +$218K | ﹤0.01% | 772 |
|
|
2017
Q3 | – | Sell |
-18,430
| Closed | -$395K | – | 1331 |
|
|
2017
Q2 | $395K | Sell |
18,430
-27,082
| -60% | -$580K | ﹤0.01% | 570 |
|
|
2017
Q1 | $780K | Buy |
45,512
+7,522
| +20% | +$129K | 0.01% | 433 |
|
|
2016
Q4 | $681K | Buy |
37,990
+16,850
| +80% | +$302K | 0.01% | 496 |
|
|
2016
Q3 | $440K | Buy |
21,140
+7,722
| +58% | +$161K | 0.01% | 446 |
|
|
2016
Q2 | $361K | Buy |
+13,418
| New | +$361K | 0.01% | 349 |
|